Skip to main content
Article
Enterococcus faecalis persistence in pediatric patients treated with antibiotic prophylaxis for recurrent urinary tract infections
Future Microbiology
  • Samantha A. Whiteside, Division of Urology
  • Sumit Dave, Division of Urology
  • Shannon L. Seney, Lawson Health Research Institute
  • Peter Wang, Division of Urology
  • Gregor Reid, Division of Urology
  • Jeremy P. Burton, Division of Urology
Document Type
Article
Publication Date
8-1-2018
URL with Digital Object Identifier
10.2217/fmb-2018-0048
Abstract

Aim: Enterococcus faecalis is one of the most common causes of recurrent urinary tract infection (RUTI), yet enterococcal pathogenesis is poorly understood. Our aims were to identify the prevalence of enterococci in RUTI patients and characterize the enterococcal response to nitrofurantoin and trimethoprim-sulfamethoxazole. Materials & methods: We studied pediatric patients receiving antibiotic prophylaxis and those only under clinical observation for 12 months (n = 39). We then assessed the response of uropathogenic E. faecalis to nitrofurantoin and trimethoprim-sulfamethoxazole. Results: Enterococci were isolated from almost half of patients and exposure of Enterococcus to nitrofurantoin increased virulence properties; this did not correlate with increased expression of virulence factors. Conclusion: Our results demonstrate that antibiotic prophylaxis may not be suitable for treatment of enterococcal RUTI (NCT02357758).

Citation Information
Samantha A. Whiteside, Sumit Dave, Shannon L. Seney, Peter Wang, et al.. "Enterococcus faecalis persistence in pediatric patients treated with antibiotic prophylaxis for recurrent urinary tract infections" Future Microbiology Vol. 13 Iss. 10 (2018) p. 1095 - 1115
Available at: http://works.bepress.com/peter-wang/2/